tiprankstipranks
Molina Healthcare (MOH)
NYSE:MOH
US Market
MOH
Molina Healthcare
RESEARCH TOOLSreports
Want to see MOH full AI Analyst Report?

Molina Healthcare (MOH) Stock Forecast & Price Target

1,178 Followers
See the Price Targets and Ratings of:

MOH Analyst Ratings

Hold
17Ratings
Hold
3 Buy
13 Hold
1 Sell
Based on 17 analysts giving stock ratings to
Molina
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MOH Stock 12 Month Forecast

Average Price Target

$172.79
▲(15.99% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Molina Healthcare in the last 3 months. The average price target is $172.79 with a high forecast of $250.00 and a low forecast of $129.00. The average price target represents a 15.99% change from the last price of $148.97.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"128":"$128","221":"$221","314":"$314","174.5":"$174.5","267.5":"$267.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":250,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$250.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":172.78571428571428,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$172.79</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":129,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$129.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[128,174.5,221,267.5,314],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,192.7,197.1076923076923,201.51538461538462,205.9230769230769,210.33076923076922,214.73846153846154,219.14615384615385,223.55384615384617,227.96153846153845,232.36923076923077,236.77692307692308,241.18461538461537,245.5923076923077,{"y":250,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,192.7,191.16813186813187,189.63626373626371,188.1043956043956,186.57252747252747,185.04065934065932,183.5087912087912,181.97692307692307,180.44505494505495,178.9131868131868,177.38131868131867,175.84945054945055,174.3175824175824,{"y":172.78571428571428,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,192.7,187.79999999999998,182.89999999999998,178,173.1,168.2,163.29999999999998,158.39999999999998,153.5,148.6,143.7,138.8,133.89999999999998,{"y":129,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":313.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.35,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":306.29,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.13,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.25,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":192.79,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153.06,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":173.54,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.18,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.42,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.82,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":192.7,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$250.00Average Price Target$172.79Lowest Price Target$129.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on MOH
Andrew Mok CFA
Barclays
Barclays
$161
Sell
8.08%
Upside
Reiterated
05/12/26
Barclays Remains a Sell on Molina Healthcare (MOH)
Morgan Stanley Analyst forecast on MOH
Erin Wright
Morgan Stanley
Morgan Stanley
$146
Hold
-1.99%
Downside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (NASDAQ: ELVN), Molina Healthcare (NYSE: MOH) and Aldeyra Therapeutics (NASDAQ: ALDX)
Truist Financial Analyst forecast on MOH
David S Macdonald
Truist Financial
Truist Financial
$180→$205
Hold
37.61%
Upside
Reiterated
05/11/26
Truist Financial Remains a Hold on Molina Healthcare (MOH)
Goldman Sachs Analyst forecast on MOH
Scott Fidel
Goldman Sachs
Goldman Sachs
$142
Hold
-4.68%
Downside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Cross Country Healthcare (NASDAQ: CCRN), Molina Healthcare (NYSE: MOH) and Treace Medical Concepts (NASDAQ: TMCI)
Cantor Fitzgerald Analyst forecast on MOH
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$144→$209
Hold
40.30%
Upside
Reiterated
05/11/26
Cantor Fitzgerald Remains a Hold on Molina Healthcare (MOH)
Bank of America Securities Analyst forecast on MOH
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$250
Buy
67.82%
Upside
Reiterated
05/11/26
Analysts Are Bullish on Top Healthcare Stocks: Molina Healthcare (MOH), Cencora (COR)
Robert W. Baird Analyst forecast on MOH
Michael Ha
Robert W. Baird
Robert W. Baird
$124→$163
Hold
9.42%
Upside
Reiterated
05/11/26
Molina Healthcare price target raised to $163 from $124 at BairdMolina Healthcare price target raised to $163 from $124 at Baird
Wells Fargo Analyst forecast on MOH
Stephen Baxter
Wells Fargo
Wells Fargo
$159
Hold
6.73%
Upside
Assigned
05/10/26
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (NYSE: MOH), Entera Bio (NASDAQ: ENTX) and Merck & Company (NYSE: MRK)
Mizuho Securities Analyst forecast on MOH
Ann Hynes
Mizuho Securities
Mizuho Securities
$195→$200
Buy
34.26%
Upside
Reiterated
05/08/26
Analysts Are Bullish on Top Healthcare Stocks: Molina Healthcare (MOH), Demant (WILLF)
J.P. Morgan Analyst forecast on MOH
John Stansel
J.P. Morgan
J.P. Morgan
―
Hold
―
Reiterated
05/08/26
Balanced Risk-Reward Keeps Molina Healthcare at Hold Amid Conservative 2029 Growth and Margin Assumptions
UBS Analyst forecast on MOH
A.J. Rice
UBS
UBS
$151→$180
Hold
20.83%
Upside
Assigned
04/24/26
Molina Healthcare price target raised to $180 from $151 at UBSMolina Healthcare price target raised to $180 from $151 at UBS
Deutsche Bank Analyst forecast on MOH
George Hill
Deutsche Bank
Deutsche Bank
$109→$129
Hold
-13.41%
Downside
Reiterated
04/24/26
Molina Healthcare price target raised to $129 from $109 at Deutsche BankMolina Healthcare price target raised to $129 from $109 at Deutsche Bank
TD Cowen Analyst forecast on MOH
Ryan Langston
TD Cowen
TD Cowen
$144→$163
Hold
9.42%
Upside
Assigned
04/24/26
Analysts Conflicted on These Healthcare Names: Molina Healthcare (NYSE: MOH), Boston Scientific (NYSE: BSX) and Praxis Precision Medicines (NASDAQ: PRAX)
Guggenheim Analyst forecast on MOH
Jason Cassorla
Guggenheim
Guggenheim
―
Hold
―
Reiterated
04/23/26
Guggenheim Remains a Hold on Molina Healthcare (MOH)
Wolfe Research Analyst forecast on MOH
Justin Lake
Wolfe Research
Wolfe Research
―
Hold
―
Reiterated
04/22/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Boston Scientific (NYSE: BSX), Amneal Pharmaceuticals (NASDAQ: AMRX) and Molina Healthcare (NYSE: MOH)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on MOH
Andrew Mok CFA
Barclays
Barclays
$161
Sell
8.08%
Upside
Reiterated
05/12/26
Barclays Remains a Sell on Molina Healthcare (MOH)
Morgan Stanley Analyst forecast on MOH
Erin Wright
Morgan Stanley
Morgan Stanley
$146
Hold
-1.99%
Downside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (NASDAQ: ELVN), Molina Healthcare (NYSE: MOH) and Aldeyra Therapeutics (NASDAQ: ALDX)
Truist Financial Analyst forecast on MOH
David S Macdonald
Truist Financial
Truist Financial
$180→$205
Hold
37.61%
Upside
Reiterated
05/11/26
Truist Financial Remains a Hold on Molina Healthcare (MOH)
Goldman Sachs Analyst forecast on MOH
Scott Fidel
Goldman Sachs
Goldman Sachs
$142
Hold
-4.68%
Downside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Cross Country Healthcare (NASDAQ: CCRN), Molina Healthcare (NYSE: MOH) and Treace Medical Concepts (NASDAQ: TMCI)
Cantor Fitzgerald Analyst forecast on MOH
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$144→$209
Hold
40.30%
Upside
Reiterated
05/11/26
Cantor Fitzgerald Remains a Hold on Molina Healthcare (MOH)
Bank of America Securities Analyst forecast on MOH
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$250
Buy
67.82%
Upside
Reiterated
05/11/26
Analysts Are Bullish on Top Healthcare Stocks: Molina Healthcare (MOH), Cencora (COR)
Robert W. Baird Analyst forecast on MOH
Michael Ha
Robert W. Baird
Robert W. Baird
$124→$163
Hold
9.42%
Upside
Reiterated
05/11/26
Molina Healthcare price target raised to $163 from $124 at BairdMolina Healthcare price target raised to $163 from $124 at Baird
Wells Fargo Analyst forecast on MOH
Stephen Baxter
Wells Fargo
Wells Fargo
$159
Hold
6.73%
Upside
Assigned
05/10/26
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (NYSE: MOH), Entera Bio (NASDAQ: ENTX) and Merck & Company (NYSE: MRK)
Mizuho Securities Analyst forecast on MOH
Ann Hynes
Mizuho Securities
Mizuho Securities
$195→$200
Buy
34.26%
Upside
Reiterated
05/08/26
Analysts Are Bullish on Top Healthcare Stocks: Molina Healthcare (MOH), Demant (WILLF)
J.P. Morgan Analyst forecast on MOH
John Stansel
J.P. Morgan
J.P. Morgan
―
Hold
―
Reiterated
05/08/26
Balanced Risk-Reward Keeps Molina Healthcare at Hold Amid Conservative 2029 Growth and Margin Assumptions
UBS Analyst forecast on MOH
A.J. Rice
UBS
UBS
$151→$180
Hold
20.83%
Upside
Assigned
04/24/26
Molina Healthcare price target raised to $180 from $151 at UBSMolina Healthcare price target raised to $180 from $151 at UBS
Deutsche Bank Analyst forecast on MOH
George Hill
Deutsche Bank
Deutsche Bank
$109→$129
Hold
-13.41%
Downside
Reiterated
04/24/26
Molina Healthcare price target raised to $129 from $109 at Deutsche BankMolina Healthcare price target raised to $129 from $109 at Deutsche Bank
TD Cowen Analyst forecast on MOH
Ryan Langston
TD Cowen
TD Cowen
$144→$163
Hold
9.42%
Upside
Assigned
04/24/26
Analysts Conflicted on These Healthcare Names: Molina Healthcare (NYSE: MOH), Boston Scientific (NYSE: BSX) and Praxis Precision Medicines (NASDAQ: PRAX)
Guggenheim Analyst forecast on MOH
Jason Cassorla
Guggenheim
Guggenheim
―
Hold
―
Reiterated
04/23/26
Guggenheim Remains a Hold on Molina Healthcare (MOH)
Wolfe Research Analyst forecast on MOH
Justin Lake
Wolfe Research
Wolfe Research
―
Hold
―
Reiterated
04/22/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Boston Scientific (NYSE: BSX), Amneal Pharmaceuticals (NASDAQ: AMRX) and Molina Healthcare (NYSE: MOH)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Molina Healthcare

3 Months
xxx
Success Rate
14/29 ratings generated profit
48%
Average Return
+0.10%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 48.28% of your transactions generating a profit, with an average return of +0.10% per trade.
1 Year
Ann HynesMizuho Securities
Success Rate
12/29 ratings generated profit
41%
Average Return
-5.99%
Copying Ann Hynes's trades and holding each position for 1 Year would result in 41.38% of your transactions generating a profit, with an average return of -5.99% per trade.
2 Years
xxx
Success Rate
14/29 ratings generated profit
48%
Average Return
-13.30%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 48.28% of your transactions generating a profit, with an average return of -13.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MOH Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
1
1
0
0
0
Buy
9
8
9
7
9
Hold
4
17
18
28
24
Sell
1
4
4
7
5
Strong Sell
0
0
0
0
0
total
15
30
31
42
38
In the current month, MOH has received 9 Buy Ratings, 24 Hold Ratings, and 5 Sell Ratings. MOH average Analyst price target in the past 3 months is 172.79.
Each month's total comprises the sum of three months' worth of ratings.

MOH Financial Forecast

MOH Earnings Forecast

Next quarter’s earnings estimate for MOH is $1.45 with a range of $0.98 to $2.28. The previous quarter’s EPS was $2.35. MOH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year MOH has Performed in-line its overall industry.
Next quarter’s earnings estimate for MOH is $1.45 with a range of $0.98 to $2.28. The previous quarter’s EPS was $2.35. MOH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year MOH has Performed in-line its overall industry.

MOH Sales Forecast

Next quarter’s sales forecast for MOH is $10.84B with a range of $10.59B to $11.05B. The previous quarter’s sales results were $10.80B. MOH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year MOH has Performed in-line its overall industry.
Next quarter’s sales forecast for MOH is $10.84B with a range of $10.59B to $11.05B. The previous quarter’s sales results were $10.80B. MOH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year MOH has Performed in-line its overall industry.

MOH Stock Forecast FAQ

What is MOH’s average 12-month price target, according to analysts?
Based on analyst ratings, Molina Healthcare’s 12-month average price target is 172.79.
    What is MOH’s upside potential, based on the analysts’ average price target?
    Molina Healthcare has 15.99% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MOH a Buy, Sell or Hold?
          Molina Healthcare has a consensus rating of Hold which is based on 3 buy ratings, 13 hold ratings and 1 sell ratings.
            What is Molina Healthcare’s price target?
            The average price target for Molina Healthcare is 172.79. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $250.00 ,the lowest forecast is $129.00. The average price target represents 15.99% Increase from the current price of $148.97.
              What do analysts say about Molina Healthcare?
              Molina Healthcare’s analyst rating consensus is a Hold. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of MOH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.